Prevalence of Asymptomatic Premalignant Oesophageal Lesions in Patients With Fanconi Anaemia
Open Access
- 16 July 2025
- journal article
- Published by Wiley in Alimentary Pharmacology & Therapeutics
- Vol. 62 (9) , 939-943
Abstract
Fanconi anaemia (FA), a rare genetic disorder of DNA repair, predisposes to squamous cell carcinomas of head, neck and oesophagus. We assessed the value of screening esophagogastroduodenoscopy (EGD) in 20 asymptomatic adults (median age 23.5, 65% female) with FA, compared to age‐and sex‐matched non‐FA patients enrolled at a 3:1 ratio. Among 11 FA patients with abnormal oesophageal mucosa, 15% had low‐grade dysplasia, nodular high‐grade dysplasia or squamous carcinoma in situ, 10% had non‐dysplastic Barrett's oesophagus and 30% had columnar epithelium without goblet cells, compared to none in the controls (p < 0.001). Our findings support routine EGD screening of asymptomatic FA patients.Keywords
This publication has 10 references indexed in Scilit:
- Fanconi anemia: current insights regarding epidemiology, cancer, and DNA repairHuman Genetics, 2022
- Treatment of Fanconi Anemia–Associated Head and Neck Cancer: Opportunities to Improve OutcomesClinical Cancer Research, 2021
- Endoscopic findings and esophageal cancer incidence among Fanconi Anemia patients participating in an endoscopic surveillance programDigestive and Liver Disease, 2019
- Screening for esophageal squamous cell carcinoma: recent advancesGastrointestinal Endoscopy, 2018
- Cancer in the National Cancer Institute inherited bone marrow failure syndrome cohort after fifteen years of follow-upHaematologica, 2017
- Alternative donor hematopoietic cell transplantation for Fanconi anemiaBlood, 2015
- How high are carrier frequencies of rare recessive syndromes? Contemporary estimates for Fanconi Anemia in the United States and IsraelAmerican Journal of Medical Genetics Part A, 2011
- Solid cancers after allogeneic hematopoietic cell transplantationBlood, 2009
- Cancer incidence in persons with Fanconi anemiaBlood, 2003
- Solid Cancers after Bone Marrow TransplantationNew England Journal of Medicine, 1997